Chronic Rhinosinusitis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CNTB | F | Connect Biopharma Holdings Limited | 1.72 | |
LYRA | F | Lyra Therapeutics, Inc. | -5.82 | |
OPTN | F | OptiNose, Inc. | -2.03 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
QQQS | A | Invesco NASDAQ Future Gen 200 ETF | 0.38 | |
IWC | B | iShares Microcap ETF | 0.01 | |
UWM | C | ProShares Ultra Russell2000 | 0.0 | |
VTWO | B | Vanguard Russell 2000 ETF | 0.0 | |
VTI | B | Vanguard Total Stock Market ETF | 0.0 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Specialty & Generic
- Chronic Rhinosinusitis
Chronic rhinosinusitis (CRS) is a long-term inflammation of the nasal passages and sinuses. It is a common condition that affects millions of people worldwide. Symptoms of CRS include nasal congestion, facial pain, postnasal drip, and a decreased sense of smell. Treatment options include medications, nasal irrigation, and surgery.
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles